26 DAFTAR PUSTAKA
1. Rubin P, Williams J, Okunieff P, Rosenblatt J, Sitzmann J. Statement of the clinical oncology problem. In: Rubin P (ed.). Clinical Oncology. Philadelphia: WB Saunders. 2001. p: 1-31.
2. Ghantoji SS, Chemaly RF. Infections in patients with leukemia. In: Popat UR (ed.). Leukemia. New York: Demos Medical Pub. 2011. p: 411-426.
3. Silverman LB. Acute lymphoblastic leukemia. In: Orkin SH, Fisher DE, Look AT, Lux IV SE, Ginsburg D, Nathan DG (ed.). Oncology of Infancy and Childhood. China: Saunders. 2009. p: 297-317. 4. Campana D, Pui CH. Childhood acute lymphoblastic leukemia. In: Hoffbrand AV, Catovsky D,
Tuddenham EGD, Green AR (ed.). Post-graduate Haematology, 6th edition. Chichester: Blackwell Publishing Ltd. 2011. p: 448-60.
5. Hughes WT, Armstrong D, Bodey GP, et. Al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002; 34: 730-751.
6. Marchetti O, Calandra T. Infections in the neutropenic cancer patients. In: Cohen J, Opal SM, Powderly WG. (ed.). Infectious Disease, 3th edition. China: Elsevier Ltd. 2010. p: 804-20. 7. Koh AY, Pizzo PA. Infectious disease in pediatric cancer. In: Orkin SH, Fisher DE, Look AT, Lux IV
SE, Ginsburg D, Nathan DG (ed.). Oncology of Infancy and Childhood. China: Saunders. 2009. p: 1100-1113.
8. Sakazaki R. Genus IV: Citrobacter. In: NR Krieg, NG Holt (ed.). Bergey’s Manual of Systemic Bacteriology, vol. 1. Baltimore: Williams and Wilkins. 1984. p: 458-461.
9. O’Hara CM, Roman SB, Miller JM. Ability of commercial identification systems to identify newly recognized species of Citrobacter. Journal of Clinical Microbiology. 1995; 33: 242-245.
10. Hart CA. Klebsiella, Citrobacter, Enterobacter and Serratia spp. In: Gillespie SH, Hawkey PM (ed.). Principles and Practise of Clinical Bacteriology, 2nd edition. Wiltshire: John Wiley & Sons Ltd. 2005. p: 377-384.
11. Bettelheim KA, Evangelidis H, Pearce JC, et. al. Isolation of a Citrobacter freundii strain which carries the Escherichia coli 0157 antigen. Journal of Clinical Microbiology. 1993; 31: 760-761. 12. Frankel G, Candy D, Everest P, Dougan D. Characterization of the C-terminal domains of
intimin-like priteins of enteropathogenic and enterohemorrhagic Escerichia coli, Citrobacter freundii and Hafnia alvei. Infection and Immunity. 1994; 62: 1835-1842.
27 13. Tschäpe H, Prager R, Streckel W, et. al. Verotoxinogenic Citrobacter freundii associated woth
severe gastroenteritis and case of haemolytic uraemic syndrome in a nursery school: green butter as the infection source. Epidemiology and Infection. 1995; 114: 441-450.
14. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med. 1991; 91 (Suppl 3B): 72-75 S.
15. Lipsky BA, Hook EW III, Smith AA, Plorde JJ. Citrobacter infections in humans: experience of the Seattle Veterans Administration Medical Center and a review of the literature. Rev Infect Dis. 1980; 2: 746-760.
16. Samonis G, Anaissie E, Elting L, Bodey GP. Review of Citrobacter bacteremia in cancer patients over a sixteen-year period. Eur J Clin Microbiol Infect Dis. 1991; 10: 479-485.
17. Engelkirk PG, Duben-Engelkirk JL. Laboratory Diagnosis of Infectious Disease: Essentials of Diagnostic Microbiology. Philadelphia: Williams & Wilkins. 2008. p: 292-322.
